@article{MTMT:32579952,
	title = {Férfiak és nők alsó húgyúti tüneteinek gyakorisága Magyarországon. egy nyílt, kérdőíves vizsgálat 2012-es évi eredményei},
	url = {https://m2.mtmt.hu/api/publication/32579952},
	author = {Majoros, Attila and Rencz, Fanni and Vártokné Hevér, Noémi and Tóth, A},
	journal-iso = {REHABILITÁCIÓ},
	journal = {REHABILITÁCIÓ: A MAGYAR REHABILITÁCIÓS TÁRSASÁG FOLYÓIRATA},
	volume = {24},
	unique-id = {32579952},
	issn = {0866-479X},
	year = {2014},
	pages = {40-40},
	orcid-numbers = {Majoros, Attila/0000-0001-7854-1083}
}

@article{MTMT:2586007,
	title = {The German approach to cost-effectiveness analysis in health care},
	url = {https://m2.mtmt.hu/api/publication/2586007},
	author = {Vártokné Hevér, Noémi and Balogh, Orsolya},
	doi = {10.1556/SocEc.2013.0008},
	journal-iso = {SOC ECON},
	journal = {SOCIETY AND ECONOMY},
	volume = {35},
	unique-id = {2586007},
	issn = {1588-9726},
	year = {2013},
	eissn = {1588-970X},
	pages = {551-572}
}

@article{MTMT:2494482,
	title = {Psoriasisban szenvedő betegek életminőségének keresztmetszeti felmérése nagy esetszámú magyarországi mintán},
	url = {https://m2.mtmt.hu/api/publication/2494482},
	author = {Balogh, Orsolya and Brodszky, Valentin and Péntek, Márta and Szegedi, Andrea and Herédi, E and Reményik, É and Holló, Péter and Jókai, H and Kárpáti, Sarolta and Gulácsi, László},
	journal-iso = {BVSZ},
	journal = {BŐRGYÓGYÁSZATI ÉS VENEROLÓGIAI SZEMLE},
	volume = {89},
	unique-id = {2494482},
	issn = {0006-7768},
	year = {2013},
	eissn = {2064-261X},
	pages = {161-161},
	orcid-numbers = {Holló, Péter/0000-0002-0744-8989; Kárpáti, Sarolta/0000-0002-8472-0712}
}

@article{MTMT:2477770,
	title = {Férfiak alsó húgyúti tüneteinek gyakorisága Magyarországon - egy nyílt kérdőíves vizsgálat eredményei},
	url = {https://m2.mtmt.hu/api/publication/2477770},
	author = {Kovács, Ágnes and Vártokné Hevér, Noémi and Tóth, Attila and Pálffy, Brigitta},
	journal-iso = {MAGYAR UROLÓGIA},
	journal = {MAGYAR UROLÓGIA},
	volume = {25},
	unique-id = {2477770},
	issn = {0864-8921},
	year = {2013},
	pages = {22-26}
}

@book{MTMT:2441386,
	title = {A BRIC országok tőkebefektetései és multinacionális cégei. Fejezetek a nemzetközi üzleti gazdaságtanból 5.},
	url = {https://m2.mtmt.hu/api/publication/2441386},
	author = {Balogh, Orsolya and Czakó, Erzsébet Hajnalka and Ferincz, Adrienn and Horváth, Viktória and Hubert, József and Katona, Viktória and Seer, László and Taródy, Dávid and Vártokné Hevér, Noémi},
	editor = {Czakó, Erzsébet Hajnalka},
	publisher = {BCE Vállalkozás és Innováció Intézet},
	unique-id = {2441386},
	year = {2013},
	orcid-numbers = {Czakó, Erzsébet Hajnalka/0009-0008-0725-7921; Czakó, Erzsébet Hajnalka/0009-0008-0725-7921}
}

@article{MTMT:2379496,
	title = {Epilepsziával élő felnőttek felmérése Magyarországon: életminőség és költségek [Survey of adults with epilepsy in Hungary: health related quality of life and costs]},
	url = {https://m2.mtmt.hu/api/publication/2379496},
	author = {Péntek, Márta and Bereczki, Dániel and Gulácsi, László and Mikudina, Boglárka and Arányi, Zsuzsanna and Juhos, Vera and Baji, Petra and Brodszky, Valentin},
	journal-iso = {IDEGGYOGY SZEMLE},
	journal = {IDEGGYOGYASZATI SZEMLE / CLINICAL NEUROSCIENCE},
	volume = {66},
	unique-id = {2379496},
	issn = {0019-1442},
	year = {2013},
	eissn = {2498-6208},
	pages = {251-261},
	orcid-numbers = {Bereczki, Dániel/0000-0002-8374-0500; Arányi, Zsuzsanna/0000-0002-8322-2498}
}

@article{MTMT:2378748,
	title = {Magánpraxis, egészségbiztosítás, szerződés és biztonság},
	url = {https://m2.mtmt.hu/api/publication/2378748},
	author = {Gulácsi, László and Baji, Petra and Kovács, Erzsébet and Farkas, Ramón and Leitner, György and Gamal, Eldin Mohamed and Simon, Tamás and Balogh, Orsolya and Boncz, Imre},
	journal-iso = {BIZTOSÍTÁSI SZEMLE},
	journal = {BIZTOSÍTÁSI SZEMLE},
	volume = {2013},
	unique-id = {2378748},
	issn = {0133-221X},
	year = {2013},
	pages = {1-29},
	orcid-numbers = {Boncz, Imre/0000-0003-3699-6236}
}

@article{MTMT:2334557,
	title = {A Clostridium difficile-fertőzések antibiotikum-terápiája. A tudományos bizonyítékok szisztematikus áttekintése és metaanalízise},
	url = {https://m2.mtmt.hu/api/publication/2334557},
	author = {Brodszky, Valentin and Gulácsi, László and Ludwig, E and Prinz, G and Banai, J and Reményi, Péter and Strbák, Bálint and Kertesz, A and Kopcsóné Németh, Irén Anna and Zsoldiné Urbán, Edit and Baji, Petra and Péntek, Márta},
	doi = {10.1556/OH.2013.29627},
	journal-iso = {ORV HETIL},
	journal = {ORVOSI HETILAP},
	volume = {154},
	unique-id = {2334557},
	issn = {0030-6002},
	abstract = {Introduction:Clostridium difficile is the leading cause of antibiotic associated infectious nosocomial diarrhoea. Limited number of new pharmaceutical products have been developed and registered in the past decades for the treatment of Clostridium difficile infection. The available scientific evidence is limited and hardly comparable. Aim: To analyse the clinical efficacy and safety of metronidazole, vancomycin and fidaxomicin in the therapy of Clostridium difficile infection. Methods: Systematic review and meta-analysis of the literature data. Results: Meta-analysis of literature data showed no significant difference between these antibiotics in clinical cure endpoint (odss ratios: fidaxomicin vs. vancomycin 1.19; vancomycin vs. metronidazol 1.69 and fidaxomicin vs. metronidazol 2.00). However, fidaxomicin therapy was significantly more effective than vancomicin and metronidazol in endpoints of recurrence and global cure (odds ratios: fidaxomicin vs. vancomycin 0.47; vancomycin vs. metronidazol 0.91 es fidaxomicin vs. metronidazol 0.43). There was no significant difference between fidaxomicin, vancomycin and metronidazole in safety endpoints. Conclusions: Each antibiotic similarly improved clinical cure. Fidaxomicin was the most effective therapeutic alternative in lowering the rate of recurrent Clostridium difficile infections. Orv. Hetil., 2013, 154, 890-899.},
	year = {2013},
	eissn = {1788-6120},
	pages = {890-899},
	orcid-numbers = {Reményi, Péter/0000-0003-3581-113X; Zsoldiné Urbán, Edit/0000-0002-9602-7552}
}

@book{MTMT:2283556,
	title = {Out-of-pocket patient payments in Hungary. Past experience and future perspectives},
	url = {https://m2.mtmt.hu/api/publication/2283556},
	isbn = {9789090271989},
	author = {Baji, Petra},
	publisher = {Universiteit Maastricht},
	unique-id = {2283556},
	year = {2013}
}

@article{MTMT:2236547,
	title = {Magyarországi perifériás verőérbetegek életminőség és betegségteher vizsgálatának eredményei [Quality of life and burden of disease in peripheral arterial disease: a study among Hungarian patients]},
	url = {https://m2.mtmt.hu/api/publication/2236547},
	author = {Balogh, Orsolya and Péntek, Márta and Gulácsi, László and Farkas, Katalin and Járai, Zoltán and Landi, A and Pecsvarady, Z and Brodszky, Valentin},
	doi = {10.1556/OH.2013.29567},
	journal-iso = {ORV HETIL},
	journal = {ORVOSI HETILAP},
	volume = {154},
	unique-id = {2236547},
	issn = {0030-6002},
	abstract = {Introduction: Peripheral arterial disease may occur in about of 14% of patients with high blood pressure, of which 1-3% suffer from chronic critical limb ischemia. Literature data on the quality of life according to the Fontaine stages are very limited. Aim: The aim of this study was to assess the quality of life of Hungarian patients with peripheral arterial disease regarding Fontaine stages II, III and IV. Methods: The study was based on a cross-sectional survey, which was carried out in four angiologic centres. One hundred and two respondents with peripheral arterial disease (43% woman) were evaluated. The average age of the patients was 70 years (SD-10). Results: Based on the EQ-5D index, the results of the quality of life assessment with respect to Fontaine stages II, III and IV were 0.66, 0.35 and 0.18, respectively. In each stage the EQ-5D values were lower than the values of the age-matched average population. The results of the Pain Visual Analogue Scale (0-100 mm) were 38, 65 and 71 mm in Fontaine stages II, III and IV, respectively, and this showed a strong correlation with the EQ-5D (R = -0.68). In stage Fontaine IV the quality of life of the patients was significantly lower among those who had pain at rest and ALSO ulcer on the leg. Conclusions: Peripheral disease with clinical symptoms causes significant reduction in quality of life which can be measured with EQ-5D. It becomes worse as we move along the Fontaine stages. While measuring the health gain in stage Fontaine IV, the health gain from the reduction of pain in rest and partial recovery from ulcer should be taken into account. Orv. Hetil., 2013, 154, 464-470.},
	year = {2013},
	eissn = {1788-6120},
	pages = {464-470}
}